Integra Lifesciences Holdings (IART) Profit After Tax (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Profit After Tax of -$4.8 million for Q2 2026, down 3.42% sequentially from -$4.6 million in Q1 2026, and up 99.03% YoY from -$2.4 million in Q2 2025.
Integra Lifesciences Holdings (IART) Profit After Tax (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Profit After Tax for 18 years, with the latest figure at -$4.8 million in Q2 2026.
- Quarterly Profit After Tax rose 99.03% year-over-year to -$4.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$13.2 million (up 97.39% YoY) and the FY2025 annual result came in at -$516.5 million, down 7337.7% from the prior year.
- Profit After Tax retreated to -$4.8 million in Q2 2026 per IART's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Profit After Tax peaked at $55.7 million in Q3 2022 and troughed at -$490.9 million in Q2 2025.
- A 5-year average of -$17.6 million and a median of $3.4 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax slumped 3858.02% in 2025, then surged 99.03% in 2026.
- Over 5 years, Profit After Tax stood at $15.2 million in 2022, then soared by 30.23% to $19.8 million in 2023, then jumped by 47.13% to $29.2 million in 2024, then sank by 90.75% to $2.7 million in 2025, then sank by 276.85% to -$4.8 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$4.8 million, -$4.6 million, and $2.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Integra Lifesciences Holdings | 1.31 Bn | 1.04 Bn | 219.74 Mn | -4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.78 Mn |
| Mar 31, 2026 | -4.62 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | -6.47 Mn |
| Jun 30, 2025 | -490.87 Mn |
| Mar 31, 2025 | -25.29 Mn |
| Dec 31, 2024 | 29.18 Mn |
| Sep 30, 2024 | -16.82 Mn |
| Jun 30, 2024 | -12.40 Mn |
| Mar 31, 2024 | -3.28 Mn |
| Dec 31, 2023 | 19.83 Mn |
| Sep 30, 2023 | 19.50 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 24.23 Mn |
| Dec 31, 2022 | 15.23 Mn |
| Sep 30, 2022 | 55.69 Mn |
| Jun 30, 2022 | 44.79 Mn |
| Mar 31, 2022 | 32.90 Mn |
| Dec 31, 2021 | 18.10 Mn |
| Sep 30, 2021 | 46.42 Mn |